SCHEMBL22211156

SCHEMBL22211156

Cc1conc1S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL294774 0.71
Fluoride SCHEMBL25376565 0.69
SCHEMBL12492838 0.67
SCHEMBL4441528 0.67
SCHEMBL2264000 0.67
SCHEMBL3575554 0.67
SCHEMBL22423681 0.67
SCHEMBL15506964 0.67
SCHEMBL20843967 0.67
SCHEMBL7046571 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3185865-B1 TETRAHYDRONAPTHTYRIDINE DERIVATIVES AS MGLUR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE. MERCK SHARP & DOHME (US) 2020-07-15 EP disclosed
CN-1493291-A Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase ��ʲ 2004-05-05 CN disclosed
CN-1140269-C Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family ��ʲ 2004-03-03 CN disclosed
CN-1139383-A Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family WARNER LAMBERT CO (US) 1997-01-01 CN disclosed